Detailed information for compound 1157229

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 190.285 | Formula: C12H18N2
  • H donors: 2 H acceptors: 0 LogP: 2.4 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccccc1NC1CCNCC1
  • InChi: 1S/C12H18N2/c1-10-4-2-3-5-12(10)14-11-6-8-13-9-7-11/h2-5,11,13-14H,6-9H2,1H3
  • InChiKey: LADSWAXVIITUMG-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0052 0.2197 0.6239
Echinococcus granulosus zinc finger protein 0.002 0.0166 0.0166
Loa Loa (eye worm) hypothetical protein 0.0044 0.1679 0.4769
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0052 0.2197 0.2197
Echinococcus multilocularis bromodomain adjacent to zinc finger domain 0.0037 0.1239 0.1239
Echinococcus multilocularis zinc finger protein 0.002 0.0166 0.0166
Schistosoma mansoni bromodomain containing protein 0.0065 0.3033 0.3033
Echinococcus multilocularis geminin 0.0174 1 1
Echinococcus multilocularis bromodomain adjacent to zinc finger domain 0.0061 0.2798 0.2798
Loa Loa (eye worm) PHD-finger family protein 0.0021 0.0235 0.0667
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0052 0.2197 0.5117
Schistosoma mansoni zinc finger protein 0.002 0.0166 0.0166
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0052 0.2197 0.2197
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.2197 0.2197
Loa Loa (eye worm) bromodomain containing protein 0.0018 0.004 0.0114
Loa Loa (eye worm) hypothetical protein 0.0073 0.3522 1
Schistosoma mansoni hypothetical protein 0.0174 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.2197 0.2197
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0052 0.2197 0.2197
Loa Loa (eye worm) hypothetical protein 0.0042 0.1554 0.4413
Schistosoma mansoni acetyl-CoA C-acetyltransferase 0.0023 0.036 0.036
Schistosoma mansoni hypothetical protein 0.0021 0.0235 0.0235
Echinococcus granulosus bromodomain adjacent to zinc finger domain 0.0037 0.1239 0.1239
Schistosoma mansoni hypothetical protein 0.0174 1 1
Brugia malayi Bromodomain containing protein 0.0077 0.3802 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.2197 0.2197
Echinococcus granulosus fetal alzheimer antigen falz 0.0023 0.036 0.036
Echinococcus granulosus bromodomain adjacent to zinc finger domain 0.0061 0.2798 0.2798
Brugia malayi Bromodomain containing protein 0.0039 0.1394 0.2673
Loa Loa (eye worm) hypothetical protein 0.0039 0.1399 0.3972
Echinococcus multilocularis fetal alzheimer antigen, falz 0.0023 0.036 0.036
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0052 0.2197 0.2197

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.